Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Gynecology

Free Subscription 09.07.2018 4 Acta Obstet Gynecol Scand 1 Am J Obstet Gynecol 5 Anticancer Res 1 BMC Cancer 2 Br J Cancer 1 Cancer Lett 1 Cancer Res 10 Gynecol Oncol 1 Int J Cancer 1 Int J Gynaecol Obstet 1 JAMA 1 Oncogene 1 PLoS Genet 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Obstet Gynecol Scand

1. SALEVAARA M, Punamaki RL, Unkila-Kallio L, Vanska M, et al
   The mental health of mothers and fathers during pregnancy and early parenthood after successful oocyte donation treatment: a nested case control study.
   Acta Obstet Gynecol Scand. 2018 Jul 5. doi: 10.1111/aogs.13421.
   PubMed     Text format     Abstract available
   
   
2. BLOMQVIST L, Hellgren M, Strandell A
   Acetylsalicylic acid does not prevent first trimester unexplained recurrent pregnancy loss: a randomized controlled trial.
   Acta Obstet Gynecol Scand. 2018 Jul 4. doi: 10.1111/aogs.13420.
   PubMed     Text format     Abstract available
   
   
3. HEDENGRAN KK, Andersen MR, Szecsi PB, Lindh C, et al
   Environmental tobacco smoke exposure during pregnancy has limited effect on infant birthweight and umbilical vein endothelial nitric oxide synthase.
   Acta Obstet Gynecol Scand. 2018 Jul 3. doi: 10.1111/aogs.13419.
   PubMed     Text format     Abstract available
   
   
4. TUJULA B, Kokki H, Rasanen J, Kokki M, et al
   Response to 'The role of procalcitonin in the diagnosis and management of infections in the field of obstetrics and gynecology'.
   Acta Obstet Gynecol Scand. 2018 Jul 2. doi: 10.1111/aogs.13417.
   PubMed     Text format     Abstract available
   
   

   
   Am J Obstet Gynecol

5. GREENWOOD EA, Pasch LA, Cedars MI, Legro RS, et al
   Association between depression, symptom experience and quality of life in polycystic ovary syndrome.
   Am J Obstet Gynecol. 2018 Jun 30. pii: S0002-9378(18)30533.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

6. ASCIUTTO KC, Forslund O, Borgfeldt C
   Prevalence of High-risk HPV in Postmenopausal Women with Benign Cervical Cytology - A Population-based Cohort Study.
   Anticancer Res. 2018;38:4221-4228.
   PubMed     Text format     Abstract available
   
   
7. TAKAHASHI Y, Hamasaki M, Aoki M, Koga K, et al
   Activated EphA2 Processing by MT1-MMP Is Involved in Malignant Transformation of Ovarian Tumours In Vivo.
   Anticancer Res. 2018;38:4257-4266.
   PubMed     Text format     Abstract available
   
   
8. IZUCHI D, Fukagawa S, Yotsumoto F, Shigekawa K, et al
   Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer.
   Anticancer Res. 2018;38:4347-4351.
   PubMed     Text format     Abstract available
   
   
9. LIAO CL, Chu YL, Lin HY, Chen CY, et al
   Bisdemethoxycurcumin Suppresses Migration and Invasion of Human Cervical Cancer HeLa Cells via Inhibition of NF-kB, MMP-2 and -9 Pathways.
   Anticancer Res. 2018;38:3989-3997.
   PubMed     Text format     Abstract available
   
   
10. ARIMA R, Marttila M, Hautakoski A, Arffman M, et al
    Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
    Anticancer Res. 2018;38:4169-4178.
    PubMed     Text format     Abstract available
    
    

    
    BMC Cancer

11. CAMPOS NG, Tsu V, Jeronimo J, Mvundura M, et al
    Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.
    BMC Cancer. 2017;17:791.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

12. HILLIARD C
    Comment on 'Dairy, calcium, vitamin D, and ovarian cancer risk in African-American women'.
    Br J Cancer. 2018 Jul 2. pii: 10.1038/s41416-018-0166.
    PubMed     Text format    
    
    
13. QIN B, Peres LC, Schildkraut JM, Bandera EV, et al
    Reply to 'Comment on 'Dairy, calcium, vitamin D and ovarian cancer risk in African-American women''.
    Br J Cancer. 2018 Jul 2. pii: 10.1038/s41416-018-0163.
    PubMed     Text format    
    
    

    
    Cancer Lett

14. MALDONADO L, Brait M, Izumchenko E, Begum S, et al
    Integrated Transcriptomic and Epigenomic Analysis of Ovarian Cancer Reveals Epigenetically Silenced GULP1.
    Cancer Lett. 2018 Jun 28. pii: S0304-3835(18)30436.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

15. 
    Correction: FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
    Cancer Res. 2018;78:3742.
    PubMed     Text format    
    
    

    
    Gynecol Oncol

16. MEYER LA, He W, Sun CC, Zhao H, et al
    Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness.
    Gynecol Oncol. 2018 Jun 29. pii: S0090-8258(18)31002.
    PubMed     Text format     Abstract available
    
    
17. TE GROOTENHUIS NC, Pouwer AW, de Bock GH, Hollema H, et al
    Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.
    Gynecol Oncol. 2018;148:622-631.
    PubMed     Text format     Abstract available
    
    
18. KANG WD, Ju UC, Kim SM
    Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology?
    Gynecol Oncol. 2018;148:305-310.
    PubMed     Text format     Abstract available
    
    
19. CASTLE PE, Pierz A, Stoler MH
    A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix.
    Gynecol Oncol. 2017 Dec 13. pii: S0090-8258(17)31548.
    PubMed     Text format     Abstract available
    
    
20. FU S, Lairson DR, Chan W, Wu CF, et al
    Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas.
    Gynecol Oncol. 2018;148:342-348.
    PubMed     Text format     Abstract available
    
    
21. MONTEALEGRE JR, Peckham-Gregory EC, Marquez-Do D, Dillon L, et al
    Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.
    Gynecol Oncol. 2017 Dec 21. pii: S0090-8258(17)31597.
    PubMed     Text format     Abstract available
    
    
22. KIM SI, Lee S, Jeong CW, Kim HS, et al
    Robot-assisted anterior pelvic exenteration in vulvovaginal malignant melanoma.
    Gynecol Oncol. 2018;148:430-431.
    PubMed     Text format     Abstract available
    
    
23. FILIPPOV-LEVY N, Cohen-Schussheim H, Trope CG, Hetland Falkenthal TE, et al
    Expression and clinical role of long non-coding RNA in high-grade serous carcinoma.
    Gynecol Oncol. 2018;148:559-566.
    PubMed     Text format     Abstract available
    
    
24. STECKLEIN SR, Frumovitz M, Klopp AH, Gunther JR, et al
    Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy.
    Gynecol Oncol. 2018;148:474-479.
    PubMed     Text format     Abstract available
    
    
25. POWELL CB, Alabaster A, Stoller N, Armstrong MA, et al
    Bone loss in women with BRCA1 and BRCA2 mutations.
    Gynecol Oncol. 2018;148:535-539.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

26. JASKULSKI S, Jung AY, Behrens S, Johnson T, et al
    Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: Assessment of mediation by inflammatory markers.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31647.
    PubMed     Text format     Abstract available
    
    

    
    Int J Gynaecol Obstet

27. MINKOBAME U, Mayi-Tsonga S, Obiang PA, Komba OM, et al
    Transient reduction in abortion-related lethality after interventions to reduce delays in provision of care at Centre Hospitalier de Libreville, Gabon.
    Int J Gynaecol Obstet. 2018 Jul 3. doi: 10.1002/ijgo.12586.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

28. MIMOTO MS, Oyler JL, Davis AM
    Evaluation and Treatment of Hirsutism in Premenopausal Women.
    JAMA. 2018;319:1613-1614.
    PubMed     Text format    
    
    

    
    Oncogene

29. HODGKINSON K, Forrest LA, Vuong N, Garson K, et al
    GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer.
    Oncogene. 2018 Jul 4. pii: 10.1038/s41388-018-0377.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

30. FUNIKOV SY, Kulikova DA, Krasnov GS, Rezvykh AP, et al
    Spontaneous gain of susceptibility suggests a novel mechanism of resistance to hybrid dysgenesis in Drosophila virilis.
    PLoS Genet. 2018;14:e1007400.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

31. CHUDECKA-GLAZ A, Cymbaluk-Ploska A, Wezowska M, Menkiszak J, et al
    Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
    PLoS One. 2018;13:e0194270.
    PubMed     Text format     Abstract available
    
    
32. YUEN WWY, Lee A, Chan PKS, Tran L, et al
    Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents.
    PLoS One. 2018;13:e0194159.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

33. STONE ML, Chiappinelli KB, Li H, Murphy LM, et al
    Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.
    Proc Natl Acad Sci U S A. 2017 Dec 4. pii: 1712514114.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: